methylprednisolone and Cutaneous T-Cell Lymphoma

methylprednisolone has been researched along with Cutaneous T-Cell Lymphoma in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's3 (60.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, CC; Teng, CL; Yeh, SP1
Chen, L; Huang, Z; Kong, J; Luo, Y; Mu, Z; Sheng, Y; Yang, Q1
Bachelez, H; Brice, P; Dubertret, L; Dupuy, A; Janin, A; Lebbé, C; Mebazaa, A; Morel, P; Moulonguet, I; Mouly, F; Rivet, J; Rybojad, M; Vignon-Pennamen, MD1
Assanasen, T; Intragumtornchai, T; Nakorn, TN; Rojnuckarin, P; Wannakrairot, P1
Borchard, F; Goerz, G; Megahed, M; Wohde, D; Zumdick, M1

Reviews

1 review(s) available for methylprednisolone and Cutaneous T-Cell Lymphoma

ArticleYear
Relapsed and refractory subcutaneous panniculitis-like T-cell lymphoma with excellent response to cyclosporine: a case report and literature review.
    Annals of hematology, 2016, Volume: 95, Issue:5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclosporine; Cytarabine; Deoxycytidine; Dexamethasone; Drug Resistance, Neoplasm; Etoposide; Gemcitabine; Humans; Immunosuppressive Agents; Lymphoma, T-Cell, Cutaneous; Male; Methylprednisolone; Multimodal Imaging; Panniculitis; Positron-Emission Tomography; Recurrence; Remission Induction; Salvage Therapy; Skin Neoplasms; Subcutaneous Fat; Tomography, X-Ray Computed

2016

Other Studies

4 other study(ies) available for methylprednisolone and Cutaneous T-Cell Lymphoma

ArticleYear
Granulomatous slack skin: assessment of disease progression and treatment response using positron emission tomography/computed tomography.
    Clinical lymphoma & myeloma, 2009, Volume: 9, Issue:6

    Topics: Adolescent; Disease Progression; Humans; Interferon-alpha; Lymphoma, T-Cell, Cutaneous; Male; Methylprednisolone; Positron-Emission Tomography; Skin Neoplasms; Tomography, X-Ray Computed

2009
ESHAP for primary cutaneous T-cell lymphomas: efficacy and tolerance in 11 patients.
    The hematology journal : the official journal of the European Haematology Association, 2005, Volume: 5, Issue:7

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Cisplatin; Cytarabine; Disease Progression; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, T-Cell, Cutaneous; Male; Methylprednisolone; Middle Aged; Retrospective Studies; Skin Neoplasms; Time Factors; Treatment Outcome

2005
Cyclosporin in subcutaneous panniculitis-like T-cell lymphoma.
    Leukemia & lymphoma, 2007, Volume: 48, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cyclosporine; Cytarabine; Doxorubicin; Etoposide; Female; Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor; Humans; Immunosuppressive Agents; Lymphoma, T-Cell, Cutaneous; Male; Methylprednisolone; Middle Aged; Panniculitis; Prednisone; Prognosis; Remission Induction; Skin Neoplasms; Treatment Outcome; Vincristine

2007
[Angioimmunoblastic lymphadenopathy accompanied by Duhring disease-like lesions ].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 1994, Volume: 45, Issue:8

    Topics: Biopsy; Dermatitis Herpetiformis; Diagnosis, Differential; Female; Humans; Immunoblastic Lymphadenopathy; Lymph Nodes; Lymphoma, T-Cell, Cutaneous; Methylprednisolone; Middle Aged; Skin; Skin Neoplasms

1994